KBC Group NV Sells 1,251,527 Shares of CVS Health Co. (NYSE:CVS)

KBC Group NV decreased its position in shares of CVS Health Co. (NYSE:CVS) by 37.3% during the third quarter, HoldingsChannel reports. The fund owned 2,102,773 shares of the pharmacy operator’s stock after selling 1,251,527 shares during the quarter. KBC Group NV’s holdings in CVS Health were worth $132,223,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth about $31,000. Reston Wealth Management LLC bought a new stake in shares of CVS Health during the 3rd quarter worth approximately $32,000. First Community Trust NA grew its position in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health in the third quarter worth $33,000. Finally, ORG Partners LLC lifted its position in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI raised their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Barclays reduced their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. Finally, Wells Fargo & Company cut their price objective on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a report on Monday, November 4th. Nine equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $73.00.

CVS Health Trading Up 0.4 %

Shares of NYSE:CVS opened at $54.27 on Thursday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $68.29 billion, a PE ratio of 13.77, a PEG ratio of 0.94 and a beta of 0.55. The business has a 50 day moving average of $59.47 and a two-hundred day moving average of $58.88. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, analysts forecast that CVS Health Co. will post 5.44 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.90%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.